Identified as the 21st member of FGF superfamily in 2000, the endocrine hormone fibroblast growth factor 21 (FGF21) has attracted considerable attention regarding the management of metabolic diseases as well as their complications7–9. This evidence concerns the gene FGF21 and Other metabolic disease.